Related Experiment Video
Updated: Apr 1, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Severe Acquired Long QT Syndrome in Childhood-Onset Systemic Lupus Erythematosus
Amy W Blasini1, Aaron Scarpa2, Daniel H Glaser3
1Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Insights
Childhood-onset systemic lupus erythematosus (cSLE) can cause severe QTc prolongation, a heart rhythm issue. Prompt immunomodulation effectively resolved this complication in a pediatric patient, underscoring the importance of timely treatment.
Area of Science:
- Pediatric Rheumatology
- Cardiology
- Immunology
Background:
- Childhood-onset systemic lupus erythematosus (cSLE) is a multisystem inflammatory disease.
- Cardiac involvement, including rhythm abnormalities, is a recognized complication of cSLE.
- Myopericarditis is a serious cardiac manifestation in pediatric lupus patients.
Background:
Childhood-onset systemic lupus erythematosus (cSLE) is a chronic inflammatory disease that can affect any organ system, including the heart. Cardiac rhythm abnormalities are a known complication.
Case Summary:
A pediatric patient presented with new-onset SLE complicated by seizures and myopericarditis. During induction immunosuppression, electrocardiogram showed severe QTc prolongation. Extensive investigation failed to identify a primary cause. Ultimately, escalation of immunosuppression led to sustained resolution of QTc prolongation.
Discussion:
While there is a known association between acute myopericarditis and QTc prolongation, this case highlights a severe prolongation of the QTc that rapidly improved only after appropriate immunomodulation and in the absence of other cardiac dysfunction.
Take-Home Messages:
This case notes the importance of expedient monitoring and treatment of severely prolonged QTc with concurrent investigation into the etiology. The case also illustrates the role of immunosuppression in the treatment of acquired long QT syndrome in cSLE.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pharmacokinetics in Pediatric Patients: Drug Excretion
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

